SENSITITRE HEAMOPHILUS/STREPTOCOCCUS PNEUMONIAE (HP) MIC PLATE by TREK DIAGNOSTIC SYSTEMS, INC.

The Sensititre Haemophilus/Streptococcus pneumoniae (HP) MIC Susceptibility plate is an in vitro diagnostic product for clinical susceptibility testing of Streptococcus pneumoniae and Haemophilus influenzae.

This 510(k) is for the removal of the statement in our package insert under Plate Reading and Interpretation of Results: "The panel may only be read manually." Replace this with: "The panel may be autoread or manually read when testing S. pneumoniae and manually read with Haemophilus." The Sensititre Haemophilus/Streptococcus pneumoniae MIC panel is for testing Streptococcus pneumoniae and Haemophilus influenzae isolates.

Device Description

Sensititre Haemophilus/Streptococcus pneumoniae (HP) MIC Susceptibility Plates.

AI/ML Overview

The provided text is a 510(k) premarket notification approval letter for the Sensititre™ Haemophilus/Streptococcus pneumoniae (HP) MIC Susceptibility Plates. This letter approves an amendment to the indications for use, specifically regarding the method of reading the susceptibility plates (manual vs. autoread).

However, the provided document does not contain the acceptance criteria or the study details proving the device meets those criteria, as requested in the prompt. The document is a regulatory approval letter based on information submitted in a 510(k) application, but it does not reproduce the detailed study information itself.

Therefore, I cannot provide the requested information based on the given text. The text only states that the FDA has reviewed the submission and found the device substantially equivalent to legally marketed predicate devices. The specifics of the performance testing, acceptance criteria, sample sizes, ground truth establishment, or expert qualifications are not present in this regulatory approval letter.

Summary

{0}------------------------------------------------

Image /page/0/Picture/1 description: The image shows the logo for the Department of Health & Human Services - USA. The logo consists of a circular seal with the text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" arranged around the perimeter. Inside the circle is a stylized symbol featuring three abstract human profiles facing to the right, with flowing lines beneath them.

MAR 2 6 2002

Food and Drug Administration 2098 Gaither Road Rockville MD 20850

Ms. Cynthia C. Knapp Director of Lab Services Trek Diagnostic Systems, Inc. 29299 Clemens Road, Suite 1-K Westlake. OH 44145

K014259 Re:

K014237
Trade/Device Name: Sensititre™ Haemophilus/Streptococcus pneumoniae (HP) MIC Susceptibility Plates

Regulation Number: 21 CFR 866.1640 Regulation Name: Antimicrobial Susceptibility Test Powder Regulatory Class: Class II Product Code: JWY Dated: December 21, 2001 Received: December 26, 2001

Dear Ms. Knapp:

We have reviewed your Section 510(k) premarket notification of intent to market the device we nave and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate for use surved in the encreativent of the enactment date of the Medical Device Amendments, or to commerce prior to they 20, 1978, in occordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.

If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it 11 your de records of such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.

Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must corply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set Orth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.

{1}------------------------------------------------

Page 2 -

This letter will allow you to begin marketing your device as described in your 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed notification. The I Dri Intellig of succiantial vour device and thus, permits your device to proceed to the market.

If you desire specific advice for your device on our labeling regulation (21 CFR Part 801 and 1 If you desire spociale arravitry four ovices), please contact the Office of Compliance at (301) 594-4588. Additionally, for questions on the promotion and advertising of your device, (301) 594-4560. Additionally, for quice at (301) 594-4639. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR 807.97). Other general information on your responsibilities under the Act may be obtained from the Division of Small Illionmation on your responsionals and Consumer Assistance at its toll-free number (800) 638-2041 or Manufacturers International and Colless "http://www.fda.gov/cdrh/dsma/dsmamain.html".

Sincerely yours,

Steven Butman

Steven I. Gutman, M.D., M.B.A. Director Division of Clinical Laboratory Devices Office of Device Evaluation Center for Devices and Radiological Health

Enclosure

{2}------------------------------------------------

510 (k) Number (If known): KO/4259

Device Name: Sensititre Haemophilus/Streptococcus pneumoniae (HP) MIC Susceptibility Plates.

Indications For Use:

This 510(k) is for the removal of the statement in our package insert under Plate Reading and Interpretation of Results: "The panel may only be read manually." Replace this and incelpretation of Rosel may be autoread or manually read when testing S. pneumoniae and manually read with Haemophilus." The Sensititre Haemophilus/Streptococcus pneumoniae MIC panel is for testing Streptococcus pneumoniae and Haemophilus influenzae isolates.

(PLEASE DO NOT WRITE BELOW THIS LINE- CONTINUE ON ANOTHER PAGE IF NEEDED)

Concurrence of CDRH, Office of Device Evaluation (ODE)

12
State of Million Company of the continues of the contributedCONSULERS COLLECTION-------

(Division Sian-Off) Division of Clinical Laboratory Devices

510(k) Number K014259

Prescription Use
(Per 21 CFR 801.109

Over-The-Counter Use

Regulation Number and Section

§ 866.1640 Antimicrobial susceptibility test powder.

(a)
Identification. An antimicrobial susceptibility test powder is a device that consists of an antimicrobial drug powder packaged in vials in specified amounts and intended for use in clinical laboratories for determining in vitro susceptibility of bacterial pathogens to these therapeutic agents. Test results are used to determine the antimicrobial agent of choice in the treatment of bacterial diseases.(b)
Classification. Class II (performance standards).